Artificial Intelligence | Machine Learning | Machine Perception Unlearn.ai | Accelerating Clinical Trials with AI


Enterprise, Biotechnology, Computer Software, Pharmaceuticals, Clinical Trials, Life Sciences San Francisco, CA, United States

Unlearn.ai

Artificial Intelligence | Machine Learning | Machine Perception


Unlearn.ai | Accelerating Clinical Trials with AI

Unlearn.ai

Biotechnology, Computer Software, Pharmaceuticals, Clinical Trials, Life Sciences


San Francisco, CA, United States

Unlearn.AI is a developer of a platform designed to make computational clinical trials. The company's platform accelerates clinical trials by supplementing control groups with synthetic patient data generated using AI, which helps in reducing the time to develop new medicines, enabling healthcare companies to sooner provide patients in need with life-saving therapies. Creating AI to simulate biology and improve the lives of patients. Unlearn was founded by scientists, who wanted to find a new, evidence-based approach. We operate based on proprietary approaches to machine learning principles and regulatory guidances.

 

Enrollment challenges and timeline delays plague clinical trials.

Twintelligent RCTs™ incorporate prognostic information from Digital Twins into randomized controlled trials to enable smaller control groups while maintaining power and generating evidence suitable for supporting regulatory decisions.

Make trials more patient-centric Clinical trials with smaller control groups are more attractive to patients. Shorten enrollment timelines Twintelligent RCTs™ reach enrollment targets faster because they require fewer patients. Increase power and confidence Twintelligent RCTs™ provide reliable evidence suitable for pivotal clinical trials.

 
 

B2G, B2B

26 to 50

Series B

N/A

Scaling Up

2017

 
 

Pharmaceuticals
Managed Health Care
Health Care Facilities & Hospitals
Computer Software
Biotechnology

N/A

Increase Efficiency

 
 

Analytics
IT and Security
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception
   Natural Language Processing
   Knowledge Representation and Reasoning


Clinical Data Analytics

Clinical Data Analytics

Digital Health Platform

Digital Health Platform

Clinical Sofware

Clinical Sofware


Image

Image

Video

Video

Audio

Audio

Text

Text

Time Series

Time Series

 

   Software


N/A


Machine Learning Algorithm

Machine Learning Algorithm

Deep Learning Algorithm

Deep Learning Algorithm

 
 

View All

View All AI/ML Jobs

Director of Biostatistics Research

San Francisco, California

Digital Marketing Associate

San Francisco, CA or Remote

Senior DevOps Engineer

San Francisco, California

 

AI/ML Professionals

Want to work at Unlearn.ai?

We can introduce you to the right person at Unlearn.ai

Talk to our Talent Team

 

5

1

$50M

Company was founded 2017 and it took almost 5 years (Apr 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

04/19/2022

Series B

$50M

Insight Partners, Radical Ventures, 8VC, DCVC, Mubadala Capital Ventures

Date : 04/19/2022

Round: Series B

$ Raised: $50M

Investors: Insight Partners, Radical Ventures, 8VC, DCVC, Mubadala Capital Ventures

 

Investors

Interested in researching Unlearn.ai?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Unlearn.ai

Request a Demo - Deal Souring Platform

 
Charles Fisher


Charles Fisher
Founder and Chief Executive Officer

Aaron Smith


Aaron Smith
Founder

Julia Coelho


Julia Coelho
Chief Commercial Officer

Graham Siegel


Graham Siegel
COO

Jonathan Walsh


Jonathan Walsh
Founder, Head of Data Science

Dana Jasek

Dana Jasek
Head of Marketing/CMO

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Unlearn.ai